SEC Form 4 · accession 0000899243-17-008522
CYNOSURE INC · CYNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian M. Barefoot
Director
Period of report
Mar 22, 2017
Accepted (ET)
Mar 24, 2017 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Mar 22, 2017 | U | 15,850 | $66.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F2 | $21.11 | Mar 22, 2017 | D | 10,648 | D | — | May 14, 2024 | Class A Common Stock | 10,648 | 0 | D |
| Stock Option (right to purchase)F2 | $35.37 | Mar 22, 2017 | D | 5,244 | D | — | May 14, 2025 | Class A Common Stock | 5,244 | 0 | D |
| Restricted Stock UnitsF4,F3 | — | Mar 22, 2017 | D | 1,272 | D | — | May 11, 2026 | Class A Common Stock | 1,272 | 0 | D |
Explanation of responses
- F1Pursuant to the terms of that certain Agreement and Plan of Merger, dated as of February 14, 2017, by and among Hologic, Inc., Minuteman Merger Sub, Inc. and Cynosure, Inc. (the "Merger Agreement"), these shares were tendered and disposed of at the Acceptance Time (all terms capitalized but not defined shall have the meaning given to them in the Merger Agreement) in exchange for the right to receive $66.00 per share, net to the seller in cash, without interest, less any required withholding taxes (the "Merger Consideration").
- F2This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each outstanding and unexercised stock option as of immediately prior to the Effective Time, whether vested or unvested, was automatically canceled and converted into the right to receive, for each underlying share, the difference between the Merger Consideration and the exercise price per share of the option.
- F3Each restricted stock unit represents a contingent right to receive one share of Cynosure, Inc.'s common stock.
- F4Pursuant to the terms of the Merger Agreement, each outstanding and unvested restricted stock unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share.